Literature DB >> 16995406

Seroprevalence of Toxoplasma gondii antibodies in cats and pigs from rural Western Amazon, Brazil.

G T Cavalcante1, D M Aguiar, D Chiebao, J P Dubey, V L A Ruiz, R A Dias, L M A Camargo, M B Labruna, S M Gennari.   

Abstract

Antibodies to Toxoplasma gondii were assayed in sera of 63 cats and 80 pigs from 71 farms located at Rondônia State, Western Amazon, Brazil, by the modified agglutination test (MAT) and the indirect immunofluorescent antibody test (IFAT). Antibodies (MAT > or = 1: 25) were found in 55 of 63 cats (87.3%) with titers of 1:25 in 2, 1:50 in 2, 1:100 in 7, 1:200 in 1, 1:400 in 2, 1:800 in 9, 1:1,600 in 6, and 1:3,200 or higher in 26 cats. By IFAT, antibodies were found in 55 cats (87.3%) with titers of 1:25 in 2, 1:50 in 1, 1:100 in 4, 1:200 in 4, 1: 400 in 1, 1:800 in 13, 1:1,600 in 12, and 1:3,200 or higher in 18 cats. In pig sera, by MAT, antibodies were found in 30 of 80 pigs (37.5%) with titers of 1:25 in 2, 1:50 in 3, 1:100 in 2, 1:200 in 8, 1:400 in 3, 1:800 in 5, 1:1,600 in 3, and 1:3,200 or higher in 4 pigs. By using the IFAT (titers > or = 1:64), antibodies were found in 35 (43.7%) pigs. The ingestion of undercooked tissues of infected pigs can be a source of T. gondii infection for humans and cats. However, the high seroprevalence of T. gondii in cats from the Amazon seems most likely to be indicative of high contamination of the environment by oocysts.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16995406     DOI: 10.1645/GE-830R.1

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  7 in total

1.  Prevalence and risk factors of toxoplasmosis among pregnant women in Fortaleza, Northeastern Brazil.

Authors:  Susann Sroka; Nina Bartelheimer; Andreas Winter; Jörg Heukelbach; Liana Ariza; Heliane Ribeiro; Fabíola Araujo Oliveira; Ajax Jose Nogueira Queiroz; Carlos Alencar; Oliver Liesenfeld
Journal:  Am J Trop Med Hyg       Date:  2010-09       Impact factor: 2.345

2.  Toxoplasma gondii in livestock in St. Kitts and Nevis, West Indies.

Authors:  Clare M Hamilton; Patrick J Kelly; Paul M Bartley; Alison Burrells; Alice Porco; Deidra Metzler; Kirsten Crouch; Jennifer K Ketzis; Elisabeth A Innes; Frank Katzer
Journal:  Parasit Vectors       Date:  2015-03-18       Impact factor: 3.876

3.  Toxoplasma gondii survey in cats from two environments of the city of Rio de Janeiro, Brazil by Modified Agglutination Test on sera and filter-paper.

Authors:  Paula F Bolais; Philippe Vignoles; Pamela F Pereira; Rafael Keim; Abdelkrim Aroussi; Khadja Ismail; Marie-Laure Dardé; Maria Regina Amendoeira; Aurélien Mercier
Journal:  Parasit Vectors       Date:  2017-02-17       Impact factor: 3.876

4.  Seroprevalence of Toxoplasma gondii infection in feral cats in Qatar.

Authors:  Sonia Boughattas; Jerzy Behnke; Aarti Sharma; Marawan Abu-Madi
Journal:  BMC Vet Res       Date:  2017-01-18       Impact factor: 2.741

5.  Copro-molecular diagnosis of the Toxoplasmatinae subfamily in dog and cat populations in northern Iran.

Authors:  Leila Izadi; Shahabeddin Sarvi; Seyed Abdollah Hosseini; Afsaneh Amouei; Mehdi Sharif; Mohammad Taghi Rahimi; Tooran Nayeri; Ahmad Daryani
Journal:  Epidemiol Health       Date:  2020-12-04

6.  Prevalence and risk factors of Toxoplasma gondii in fattening pigs farm from Yucatan, Mexico.

Authors:  A Ortega-Pacheco; K Y Acosta Viana; E Guzmán-Marín; J C Segura-Correa; M Alvarez-Fleites; M Jiménez-Coello
Journal:  Biomed Res Int       Date:  2013-06-06       Impact factor: 3.411

7.  Serosurvey of Smooth Brucella, Leptospira spp. and Toxoplasma gondii in Free-Ranging Jaguars (Panthera onca) and Domestic Animals from Brazil.

Authors:  Mariana Malzoni Furtado; Solange Maria Gennari; Cassia Yumi Ikuta; Anah Tereza de Almeida Jácomo; Zenaide Maria de Morais; Hilda Fátima de Jesus Pena; Grasiela Edith de Oliveira Porfírio; Leandro Silveira; Rahel Sollmann; Gisele Oliveira de Souza; Natália Mundim Tôrres; José Soares Ferreira Neto
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.